z-logo
open-access-imgOpen Access
Is the current use of ‘positivity’ thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints?
Author(s) -
Laura Richert,
Rodolphe Thiébaut
Publication year - 2013
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328360d52e
Subject(s) - immunogenicity , medicine , human immunodeficiency virus (hiv) , hiv vaccine , virology , immunology , aids vaccines , vaccine trial , antibody
International audienc

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom